Tag: Tigertriever

rapid medical tigertriever 13

Rapid Medical gains US FDA clearance for “smallest and only” adjustable...

Rapid Medical announced at the ongoing Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) that it has recently received US...

Rapid Medical begins enrolment in DISTALS trial treating new ischaemic stroke...

Rapid Medical announced today the enrolment of the first patient in the DISTALS study, which the company claims is the first-ever US Food and...
rapid medical tigertriever 13

Rapid Medical to initiate trial expanding thrombectomy treatment across distal regions...

Rapid Medical today announced US Food and Drug Administration (FDA) investigational device exemption (IDE) approval for what it claims is the first ever trial...

New thrombectomy device offers promising results

In a late-breaking presentation given on the final day of the International Stroke Conference (ISC) virtual meeting (17–19 March), researchers presented a “promising” new...

Tigertriever receives FDA clearance following ISC presentation

Rapid Medical has announced the US Food and Drug Administration (FDA) clearance of its Tigertriever revascularisation device for use in the treatment of ischaemic stroke. According...

Enrolment completed early for Rapid Medical’s TIGER study for thrombectomy device

Rapid Medical has announced that it has completed enrolment in the TIGER (Treatment with Intent to generate reperfusion) study ahead of the planned scheduled....

First patient enrolled in TIGER pivotal clinical study

The first patients have been enrolled in the TIGER (Treatment with Intent to Generate Reperfusion) study. This is a multicentre study of the performance...

First patient enrolled in TIGERTRIEVER acute ischaemic stroke registry

  The first patient has been enrolled in the TIGERTRIEVR registry at the Cantonal Hospital of Lucerne, Switzerland. The Tigertriever (Rapid Medical) is a one-of-a-kind, fully-visible,...

Rapid Medical announces $9M in new funding

Rapid Medical has completed a Series B financing of $9M to advance the commercialisation of the company’s minimally invasive stroke treatment and prevention products, the Tigertriever...

First stroke patient treated with Rapid Medical’s Tigertriever

Rapid Medical’s Tigertriever has been used to treat its first patient. Using Rapid Medical’s proprietary technology, this stent retriever is designed to be fully...

First stroke patient treated with Rapid Medical’s Tigertriever

Using Rapid Medical's proprietary technology, this stent retriever is designed to be fully visible and controllable. The device can be adjusted by physicians to fit the dimensions of blood vessels causing acute ischaemic stroke, and is the first of its kind, according to the company.